Fig. 2: Survival after diagnosis of a subsequent malignancy (SMN), and cumulative incidence of death due to SMN. | Leukemia

Fig. 2: Survival after diagnosis of a subsequent malignancy (SMN), and cumulative incidence of death due to SMN.

From: Incidence of subsequent malignancies after total body irradiation-based allogeneic HSCT in children with ALL – long-term follow-up from the prospective ALL-SCT 2003 trial

Fig. 2

A Overall (OS, solid line) and event-free survival (EFS, dashed line; event = relapse of SMN or ALL, additional SMN, death) after diagnosis of first SMN. B Cumulative incidence of death: all deaths (solid line), death due to SMN (dashdotted line) and death due to another reason (dashed line).

Back to article page